Avicanna Inc. (AVCNF)
AVCNF Stock Price Chart
Explore Avicanna Inc. interactive price chart. Choose custom timeframes to analyze AVCNF price movements and trends.
AVCNF Company Profile
Discover essential business fundamentals and corporate details for Avicanna Inc. (AVCNF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
8 Jan 2021
Employees
87.00
Website
https://www.avicanna.comCEO
Aras Azadian B.Econ, Mba
Description
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. The company collaborates with Canadian academic and medical institutions. Its scientific platform includes research and development, and clinical development that leads to the commercialization of approximately twenty products across four main market segments. The company provides medical and wellness products containing cannabidiol, cannabigerol, and tetrahydrocannabinol under the RHO Phyto brand; functional CBD consumer derma-cosmetic and topical products under the Pura H&W and Pura Earth brand names; and cannabis dried flowers, standardized seeds, full spectrum extracts, cannabinoid distillates, isolated cannabinoids, and bulk formulations derived from hemp and cannabis cultivars under the Aureus brand. It also develops pharmaceutical products for epidermolysis bullosa, dermatology, chronic pain, and various neurological disorders. The company has research collaboration with Dr. Christine Allen'sResearch Group for the development of a cannabinoid-based treatment for lung inflammation associated with COVID19. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.
AVCNF Financial Timeline
Browse a chronological timeline of Avicanna Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 12 May 2026
Upcoming earnings on 13 Nov 2025
Earnings released on 13 Aug 2025
EPS came in at -$0.00 , while revenue for the quarter reached $4.52M .
Earnings released on 14 May 2025
EPS came in at $0.00 , while revenue for the quarter reached $4.44M .
Earnings released on 11 Apr 2025
EPS came in at $0.00 , while revenue for the quarter reached $4.60M .
Earnings released on 14 Nov 2024
EPS came in at -$0.01 , while revenue for the quarter reached $4.62M .
Earnings released on 14 Aug 2024
EPS came in at -$0.02 , while revenue for the quarter reached $4.48M , beating expectations by +465.44%.
Earnings released on 14 May 2024
EPS came in at -$0.01 , while revenue for the quarter reached $4.75M , beating expectations by +499.32%.
Earnings released on 2 Apr 2024
EPS came in at -$0.02 , while revenue for the quarter reached $4.56M .
Earnings released on 15 Nov 2023
EPS came in at -$0.01 , while revenue for the quarter reached $4.62M , beating expectations by +482.88%.
Earnings released on 15 Aug 2023
EPS came in at -$0.02 , while revenue for the quarter reached $2.50M , beating expectations by +215.95%.
Earnings released on 16 May 2023
EPS came in at -$0.02 falling short of the estimated -$0.02 by -10.48%, while revenue for the quarter reached $864.81K , beating expectations by +9.19%.
Earnings released on 14 Mar 2023
EPS came in at -$0.07 , while revenue for the quarter reached $846.71K , beating expectations by +6.91%.
Earnings released on 11 Nov 2022
EPS came in at -$0.04 falling short of the estimated -$0.02 by -62.96%, while revenue for the quarter reached $563.20K , missing expectations by -68.82%.
Earnings released on 15 Aug 2022
EPS came in at -$0.06 falling short of the estimated -$0.03 by -100.58%, while revenue for the quarter reached $855.97K , missing expectations by -47.51%.
Earnings released on 30 Mar 2022
EPS came in at -$0.18 falling short of the estimated -$0.06 by -200.00%, while revenue for the quarter reached $830.23K , missing expectations by -38.89%.
Earnings released on 2 Feb 2022
EPS came in at -$0.14 , while revenue for the quarter reached $955.04K , beating expectations by +20.59%.
Earnings released on 12 Nov 2021
EPS came in at -$0.05 , while revenue for the quarter reached $779.31K .
Earnings released on 6 Sept 2021
EPS came in at -$0.14 falling short of the estimated -$0.04 by -250.00%, while revenue for the quarter reached $639.13K .
Earnings released on 3 Sept 2021
EPS came in at -$0.18 falling short of the estimated -$0.08 by -125.00%, while revenue for the quarter reached $215.54K .
Earnings released on 31 Dec 2020
EPS came in at -$0.36 , while revenue for the quarter reached -$221.11K .
Earnings released on 11 Nov 2020
EPS came in at -$0.35 , while revenue for the quarter reached $662.46K .
AVCNF Stock Performance
Access detailed AVCNF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.